Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jeffrey W, Froude"'
Autor:
Krista Meserve, Abraham J. Qavi, M. Javad Aman, Hong Vu, Larry Zeitlin, John M. Dye, Jeffrey W. Froude, Daisy W. Leung, Lan Yang, Frederick W. Holtsberg, Gaya K. Amarasinghe, Ryan C. Bailey
Publikováno v:
STAR Protocols, Vol 3, Iss 4, Pp 101719- (2022)
Summary: This protocol describes the use of silicon photonic microring resonator sensors for detection of Ebola virus (EBOV) and Sudan virus (SUDV) soluble glycoprotein (sGP). This protocol encompasses biosensor functionalization of silicon microring
Externí odkaz:
https://doaj.org/article/e9bbcc7f59114f908957058b53e324a5
Autor:
Kathryn McGuckin Wuertz, Erica K. Barkei, Wei-Hung Chen, Elizabeth J. Martinez, Ines Lakhal-Naouar, Linda L. Jagodzinski, Dominic Paquin-Proulx, Gregory D. Gromowski, Isabella Swafford, Akshaya Ganesh, Ming Dong, Xiankun Zeng, Paul V. Thomas, Rajeshwer S. Sankhala, Agnes Hajduczki, Caroline E. Peterson, Caitlin Kuklis, Sandrine Soman, Lindsay Wieczorek, Michelle Zemil, Alexander Anderson, Janice Darden, Heather Hernandez, Hannah Grove, Vincent Dussupt, Holly Hack, Rafael de la Barrera, Stasya Zarling, James F. Wood, Jeffrey W. Froude, Matthew Gagne, Amy R. Henry, Elham Bayat Mokhtari, Prakriti Mudvari, Shelly J. Krebs, Andrew S. Pekosz, Jeffrey R. Currier, Swagata Kar, Maciel Porto, Adrienne Winn, Kamil Radzyminski, Mark G. Lewis, Sandhya Vasan, Mehul Suthar, Victoria R. Polonis, Gary R. Matyas, Eli A. Boritz, Daniel C. Douek, Robert A. Seder, Sharon P. Daye, Mangala Rao, Sheila A. Peel, M. Gordon Joyce, Diane L. Bolton, Nelson L. Michael, Kayvon Modjarrad
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-11 (2021)
Abstract The emergence of SARS-CoV-2 variants of concern (VOC) requires adequate coverage of vaccine protection. We evaluated whether a SARS-CoV-2 spike ferritin nanoparticle vaccine (SpFN), adjuvanted with the Army Liposomal Formulation QS21 (ALFQ),
Externí odkaz:
https://doaj.org/article/3d4762c8ae9d4d3e8004ffeb07a8b88e
Autor:
Jeffrey M, Osgood, Jeffrey W, Froude, Sherri P, Daye, Oscar A, Cabrera, Matthew R, Scherer, Vincent F, Capaldi, Nelson L, Michael, James E, Moon, Eric D, Lombardini, Sheila A, Peel, Karen P, Peterson, Deydre S, Teyhen, Clinton K, Murray, Robert J, O'Connell
Publikováno v:
Military Medicine
Introduction At the start of the coronavirus disease 2019 (COVID-19) pandemic, Walter Reed Army Institute of Research (WRAIR) mobilized to rapidly conduct medical research to detect, prevent, and treat the disease in order to minimize the impact of t
Autor:
Sandrine Soman, Shelly J. Krebs, Diane L. Bolton, Gregory D. Gromowski, Ines Lakhal-Naouar, Swagata Kar, Michelle Zemil, Linda L. Jagodzinski, Amy R. Henry, Robert A. Seder, Lindsay Wieczorek, Hannah Grove, Dominic Paquin-Proulx, Adrienne Winn, Daniel C. Douek, Holly R. Hack, Caitlin Kuklis, Kamil Radzyminski, Rafael De La Barrera, Matthew Gagne, Caroline E. Peterson, James F. Wood, Heather Hernandez, Alexander R. A. Anderson, Xiankun Zeng, Stasya Zarling, Wei-Hung Chen, Mark G. Lewis, Rajeshwer S. Sankhala, Prakriti Mudvari, Andrew Pekosz, Victoria R. Polonis, Maciel Porto, Mangala Rao, Paul V. Thomas, Eli Boritz, M. Gordon Joyce, Sheila A. Peel, Elham Bayat Mokhtari, Kathryn McGuckin Wuertz, Nelson L. Michael, Sharon P. Daye, Akshaya Ganesh, Agnes Hajduczki, Gary R. Matyas, Jeffrey W. Froude, Vincent Dussupt, Erica K. Barkei, Kayvon Modjarrad, Jeffrey R. Currier, Sandhya Vasan, Janice Darden, Isabella Swafford, Elizabeth J. Martinez, Mehul S. Suthar, Ming Dong
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-11 (2021)
NPJ Vaccines
NPJ Vaccines
The emergence of SARS-CoV-2 variants of concern (VOC) requires adequate coverage of vaccine protection. We evaluated whether a SARS-CoV-2 spike ferritin nanoparticle vaccine (SpFN), adjuvanted with the Army Liposomal Formulation QS21 (ALFQ), conferre
Autor:
Jeffrey R. Kugelman, Johanny Kugelman-Tonos, Jason T. Ladner, James Pettit, Carolyn M. Keeton, Elyse R. Nagle, Karla Y. Garcia, Jeffrey W. Froude, Ana I. Kuehne, Jens H. Kuhn, Sina Bavari, Larry Zeitlin, John M. Dye, Gene G. Olinger, Mariano Sanchez-Lockhart, Gustavo F. Palacios
Publikováno v:
Cell Reports, Vol 12, Iss 12, Pp 2111-2120 (2015)
MB-003, a plant-derived monoclonal antibody cocktail used effectively in treatment of Ebola virus infection in non-human primates, was unable to protect two of six animals when initiated 1 or 2 days post-infection. We characterized a mechanism of vir
Externí odkaz:
https://doaj.org/article/dc883dcf66c3464cadf39bdec67933ae
Autor:
Do Jin Kim, Greta Van Slyke, Miles B. Brennan, Nicholas J. Mantis, Peter J. Didier, Neil Mlakar, Zachary A. Bornholdt, Ellen S. Vitetta, Dylan J. Ehrbar, Lioudmila Campbell, Kevin J. Whaley, Fernando J Torres-Velez, Chad J. Roy, Michelle Chen, Larry Zeitlin, Jeffrey W Froude, Lara A. Doyle-Meyers
Publikováno v:
npj Vaccines, Vol 5, Iss 1, Pp 1-8 (2020)
NPJ Vaccines
NPJ Vaccines
Inhalation of ricin toxin (RT), a Category B biothreat agent, provokes an acute respiratory distress syndrome marked by pro-inflammatory cytokine and chemokine production, neutrophilic exudate, and pulmonary edema. The severity of RT exposure is attr
Publikováno v:
Toxins, Vol 3, Iss 11, Pp 1433-1452 (2011)
B. anthracis is a bioweapon of primary importance and its pathogenicity depends on its lethal and edema toxins, which belong to the A-B model of bacterial toxins, and on its capsule. These toxins are secreted early in the course of the anthrax diseas
Externí odkaz:
https://doaj.org/article/a446366ff0dc4e12a3e30200ba61dda1
Autor:
Jeffrey W. Froude, Andrew S. Herbert, Thibaut Pelat, Sebastian Miethe, Samantha E. Zak, Jennifer M. Brannan, Russell R. Bakken, Alexander R. Steiner, Gang Yin, Trevor J. Hallam, Aaron K. Sato, Michael Hust, Philippe Thullier, John M. Dye
Publikováno v:
Viruses, Vol 10, Iss 6, p 286 (2018)
Sudan virus (SUDV) and Ebola viruses (EBOV) are both members of the Ebolavirus genus and have been sources of epidemics and outbreaks for several decades. We present here the generation and characterization of cross-reactive antibodies to both SUDV a
Externí odkaz:
https://doaj.org/article/b3dfacf3f5d44be69f0dabd0c49fbe68
Autor:
Crystal W. Burke, Jeffrey W. Froude, Sebastian Miethe, Birgit Hülseweh, Michael Hust, Pamela J. Glass
Publikováno v:
Viruses, Vol 10, Iss 4, p 147 (2018)
Western equine encephalitis virus (WEEV) causes symptoms in humans ranging from mild febrile illness to life-threatening encephalitis, and no human medical countermeasures are licensed. A previous study demonstrated that immune serum from vaccinated
Externí odkaz:
https://doaj.org/article/2f22cb5857c544d9ba9e1bce01b9cbde
Autor:
Kathryn McGuckin Wuertz, Matthew Gagne, Sharon P. Daye, Gary R. Matyas, Erica K. Barkei, Swagata Kar, Rafael De La Barrera, Caroline E. Peterson, Elyham Bayat Mokhtari, Michelle Zemil, Linda L. Jagodzinski, Elizabeth J. Martinez, Sandrine Soman, Mehul S. Suthar, Wei-Hung Chen, M. Gordon Joyce, Sheila A. Peel, Dominic Paquin-Proulx, Heather Hernandez, Rajeshwer S. Sankhala, Sandhya Vasan, Stasya Zarling, Caitlin Kuklis, Janice Darden, Andrew Pekosz, Diane L. Bolton, Ming Dong, Mark G. Lewis, Xiankun Zeng, Paul V. Thomas, Victoria R. Polonis, James F. Wood, Marciel Porto, Prakriti Mudvari, Ines Elakhal Naouar, Daniel C. Douek, Shelly J. Krebs, Holly R. Hack, Mangala Rao, Eli Boritz, Gregory D. Gromowski, Kamil Radzyminski, Robert A. Seder, Alexander R. A. Anderson, Akshaya Ganesh, Hannah Grove, Isabella Swafford, Amy R. Henry, Adrienne Winn, Agnes Hajduczki, Nelson L. Michael, Kayvon Modjarrad, Jeffrey W. Froude, Lindsey Wieczorek, Vincent Dussupt, Jeffrey R. Currier
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
The emergence of SARS-CoV-2 variants of concern (VOC) requires adequate coverage of vaccine protection. We evaluated whether a spike ferritin nanoparticle vaccine (SpFN), adjuvanted with the Army Liposomal Formulation QS21 (ALFQ), conferred protectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f22541b3a4b216dde47acf2f8f3ef8
https://doi.org/10.1101/2021.06.16.448525
https://doi.org/10.1101/2021.06.16.448525